Tagged with Policy

Pharma Gets to Grips with the Inflation Reduction Act
Germany: The Impact of Cost Containment Reform on Biopharma
The Inflation Reduction Act & the Economics of Drug Development
Understaffed if not Deserted: What’s Ailing French Healthcare?
Plausible Outcomes for Healthcare in the Wake of Brazil’s Presidential Runoff
UK’s NHS Facing Major Leadership Shake-Up
Nathalie Moll, Director General – European Federation of Pharmaceutical Industries and Associations (EFPIA)
Japan Healthcare and Pharma News: COVID-19 pill from Shionogi, Takeda’s bounce back from profit drop, Hitachi/Invivoscribe partnership …
Pharmaceuticals Take Centre Stage in Australian Election Campaign
Australia National Medicines Policy Revision Reshaped by Community Feedback
US Pharma & Healthcare News: California Debates UHC; Mark Cuban’s “Lifesaving” Affordable Online Pharmacy; $400M Expansion for DHL
US Health Policy: FDA Calls for Federal Investigation of Itself on Aduhelm; Funding Boost for Medicare, Medicaid, ObamaCare; Questions over Benefits of New Science Agency
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here